Oral lacosamide for the treatment of refractory trigeminal neuralgia: A retrospective analysis of 86 cases

Author:

Muñoz‐Vendrell Albert12ORCID,Tena‐Cucala Raquel1ORCID,Campoy Sergio13ORCID,García‐Parra Belia4,Prat Joan1,Martínez‐Yélamos Sergio2ORCID,Huerta‐Villanueva Mariano13ORCID

Affiliation:

1. Neurology Service, Headache Unit Hospital Universitari de Bellvitge‐IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat Barcelona Spain

2. Neurology Service, Multiple Sclerosis Unit Hospital Universitari de Bellvitge‐IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat Barcelona Spain

3. Neurology Department Hospital de Viladecans‐IDIBELL Viladecans, Barcelona Spain

4. Neurology Service, Neurophysiology Department Hospital Universitari de Bellvitge‐IDIBELL, Universitat de Barcelona, L'Hospitalet de Llobregat Barcelona Spain

Abstract

AbstractBackground and ObjectivesFirst‐line treatment for trigeminal neuralgia (TN) is limited to carbamazepine and oxcarbazepine, and in refractory cases, alternatives are scarce. Lacosamide has been suggested as a valid option. In this study, we describe a series of patients who received oral lacosamide as treatment for TN after first‐line drug failure.MethodsIn this retrospective descriptive cohort study, we included patients with refractory TN who attended a tertiary center between 2015 and 2021 and were prescribed oral lacosamide after first‐line treatment failure. The primary endpoints were pain relief and adverse effects. We secondarily analyzed clinical outcomes and compared responders versus nonresponders in the search for potential predictors of response.ResultsEighty‐six patients were included (mean age: 62 [SD 15.6] years; 54/86 [63%] female). The TN etiology was secondary in 16/86 (19%) patients. Concomitant continuous pain was present in 29/86 (34%) patients. The mean number of previous treatments was 2.7 [SD 1.5]. Pain relief was achieved in 57/86 (66%) cases, with 28/86 (33%) patients presenting adverse effects, all of which were mild. No statistically significant differences were observed between responders and nonresponders, but subtle clinical differences suggested potential predictors of response.ConclusionLacosamide may be an effective and relatively safe treatment for refractory pain in TN patients after first‐line treatment failure.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3